PROCEPT BioRobotics Corporation
PRCT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $83 | $79 | $69 | $68 |
| % Growth | 5.2% | 14.5% | 1.4% | – |
| Cost of Goods Sold | $29 | $27 | $25 | $25 |
| Gross Profit | $54 | $52 | $44 | $44 |
| % Margin | 64.8% | 65.4% | 63.9% | 64% |
| R&D Expenses | $18 | $18 | $16 | $15 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $59 | $56 | $55 | $48 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $77 | $74 | $72 | $63 |
| Operating Income | -$23 | -$22 | -$27 | -$20 |
| % Margin | -27.8% | -28% | -39.7% | -28.9% |
| Other Income/Exp. Net | $2 | $3 | $3 | $1 |
| Pre-Tax Income | -$21 | -$20 | -$25 | -$19 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$21 | -$20 | -$25 | -$19 |
| % Margin | -25.7% | -24.7% | -35.8% | -27.6% |
| EPS | -0.38 | -0.35 | -0.45 | -0.35 |
| % Growth | -8.6% | 22.2% | -28.6% | – |
| EPS Diluted | -0.38 | -0.35 | -0.45 | -0.35 |
| Weighted Avg Shares Out | 56 | 55 | 55 | 54 |
| Weighted Avg Shares Out Dil | 56 | 55 | 55 | 54 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $4 | $4 | $3 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $2 | $2 | $1 | $1 |
| EBITDA | -$19 | -$17 | -$22 | -$16 |
| % Margin | -22.7% | -21.6% | -32.4% | -24.1% |